Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier in Psychiatry Research
- Vol. 36 (1), 1-17
- https://doi.org/10.1016/0165-1781(91)90113-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Serotonin Agonists Cause Parallel Activation of the Sympathoadrenomedullary System and the Hypothalamo-Pituitary-Adrenocortical Axis in Conscious RatsEndocrinology, 1989
- Elevated antidepressant plasma levels after addition of fluoxetineAmerican Journal of Psychiatry, 1989
- Treatment of Obsessive Compulsive Disorder with ClomipraminePsychiatric Annals, 1989
- Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalamiPeptides, 1989
- Clomipramine in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1989
- Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetinePsychopharmacology, 1988
- Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeysLife Sciences, 1983
- Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazineLife Sciences, 1983
- Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosisProgress in Neuro-Psychopharmacology, 1981
- The clinical application of tricyclic antidepressant pharmacokinetics and plasma levelsAmerican Journal of Psychiatry, 1980